SUBSCRIBE
SUBSCRIBE

Phase I

Drug Development
Will AbbVie Outsmart Biosimilars, And Can Clovis Oncology Win The PARP Race?
June 27, 2017
 · 
1 min read
Massachusetts' Biostage Slashes 71% of Staff, Evaluating Strategic Alternatives
Drug Development
A Look at the Deaths That Plagued Juno and Kite Pharma’s CAR-T Trials
June 27, 2017
 · 
3 min read
Why This Tiny Biotech is Giving Cash to Amgen Researchers
Drug Development
Amgen Goes on the Defensive When Critics Call Its Pipeline a Dud
June 22, 2017
 · 
2 min read
BIO2017: Companies Highlight Numerous Innovations During San Diego Convention
Drug Development
BIO2017: After IPO, Full Speed Ahead for San Diego’s Tocagen
June 16, 2017
 · 
2 min read
Drug Development
While Amgen-Size Biotechs Run Into Trouble, These Are The Biotechs With The Most Promising Pipelines
June 16, 2017
 · 
1 min read
Proteostasis and Roche Diagnostics Ink Huge Space in New Boston Hub
Drug Development
New Data Reveals This New York Biotech’s Pipeline Could be a Game Changer
June 16, 2017
 · 
2 min read
Drug Development
Helsinn And MEI Pharma Announce First Patient Dosed In Phase II Dose-Optimization Study Of Pracinostat And Azacitidine In Myelodysplastic Syndrome
June 14, 2017
 · 
8 min read
3 Biotechs That Could be Taken Out This Quarter
Drug Development
Why Drug Giants Like Merck & Co. and AstraZeneca PLC Scientists are Looking in the Toilet for New Cancer Treatments
June 14, 2017
 · 
2 min read
Tiny Bay Area Biotech Wants to Rattle the Billion-Dollar Injectable Drug Markets With a Single Pill
Drug Development
Tiny Bay Area Biotech Wants to Rattle the Billion-Dollar Injectable Drug Markets With a Single Pill
June 8, 2017
 · 
2 min read
Drug Development
AbbVie Testosterone Gel Faces Scrutiny As First Trial Begins
June 7, 2017
 · 
1 min read
Load More
PRESS RELEASES
Drug Development
LIXTE Biotechnology and the Spanish Sarcoma Group Enroll First Patient in a Phase 1b/2 Randomized Trial of Doxorubicin +/- LIXTE’s Lead Anti-Cancer Compound, LB-100, in Advanced Soft Tissue Sarcomas
June 7, 2023
 · 
5 min read
Drug Development
Nascent Biotech Phase I Clinical Data Presented at the American Society of Clinical Oncology Annual Meeting
June 7, 2023
 · 
2 min read
Drug Development
BeyondSpring and Leading Cancer Center Present Poster Highlighting Plinabulin’s Ability to Reduce Infectious Neutropenic Fever for Multiple Myeloma Patients Undergoing AHCTData Presented at 2023 ASCO Annual Meeting
June 7, 2023
 · 
2 min read
Drug Development
BioInvent Announces Additional Efficacy Data from Intravenous Part of Phase 1/2 Trial with BI-1206 in Solid Tumors
June 7, 2023
 · 
4 min read
Drug Development
ImmVira presented latest encouraging clinical results of two proprietary products at ASCO 2023
June 6, 2023
 · 
5 min read
Drug Development
Oncternal Therapeutics Announces First Patient Dosed in Phase 1/2 Study of ROR1 targeting autologous CAR T, ONCT-808, in patients with relapsed or refractory aggressive B-cell lymphoma
June 6, 2023
 · 
6 min read
Drug Development
Eureka Therapeutics Awarded $10.6 Million CIRM Grant to Support Clinical Trial of ARTEMIS® T-Cell Therapy in Pediatric Liver Cancer
June 6, 2023
 · 
3 min read
Drug Development
Repare Therapeutics Announces Publication in Nature Medicine Highlighting Clinical Benefit of Camonsertib in Advanced Solid Tumors
June 6, 2023
 · 
6 min read
Drug Development
Promising 2-year updated data from cadonilimab presented at 2023 ASCO highlighting promising efficacy in PD-L1-negative patients
June 6, 2023
 · 
4 min read
Drug Development
Precigen Announces Positive Phase 1 Data for PRGN-3005 Autologous UltraCAR-T® Cells Manufactured Overnight for Infusion Next Day to Advanced Stage Platinum Resistant Ovarian Cancer Patients
June 5, 2023
 · 
14 min read
Drug Development
Erasca Provides Update on Clinical Program for ERK Inhibitor ERAS-007 and Refines Pipeline
June 5, 2023
 · 
10 min read
Drug Development
Fulgent Data at ASCO 2023 Highlights Progress for Its Lead Therapeutic Oncology Candidate, FID-007, in Various Cancers
June 5, 2023
 · 
6 min read
Drug Development
FogPharma Announces First Patient Dosed in Phase 1/2 Clinical Trial of First-in-class TCF-blocking β-catenin Inhibitor, FOG-001, in Advanced Solid Tumors
June 5, 2023
 · 
4 min read
Business
Datopotamab deruxtecan combinations showed encouraging tumor responses in patients with advanced non-small cell lung cancer in TROPION-Lung02 Phase Ib trial
June 5, 2023
 · 
13 min read
Drug Development
Vaxxas Announces Interim Results from Phase I Clinical Study of First Needle-Free COVID-19 Vaccine Delivered Using Proprietary High-Density Microarray Patch (HD-MAP)
June 5, 2023
 · 
6 min read
Drug Development
OrsoBio Announces Phase 1 Trial of TLC-6740, a Mitochondrial Protonophore for the Treatment of Obesity and Associated Diseases
June 5, 2023
 · 
4 min read
Drug Development
Datopotamab Deruxtecan Combinations Showed Encouraging Tumor Responses in Patients with Advanced Non-Small Cell Lung Cancer in TROPION-Lung02 Phase 1b trial
June 5, 2023
 · 
12 min read
Drug Development
NexImmune Presents Initial Positive Data from the NEXI-001 Phase 1 Trial for Relapsed/Refractory Post Allo-HSCT AML at the American Society of Clinical Oncology 2023 Annual Meeting
June 5, 2023
 · 
9 min read
Drug Development
Portage Biotech Reports Updated Interim Data for Lead iNKT Engager, PORT-2, in a Phase 1/2 Trial for the Treatment of Advanced Melanoma and Metastatic Non-Small Cell Lung Cancer at the 2023 ASCO Annual Meeting
June 5, 2023
 · 
6 min read
Drug Development
Taysha Gene Therapies Announces First Patient Dosed with TSHA-102 in the REVEAL Phase 1/2 Trial Under Investigation for the Treatment of Rett Syndrome
June 5, 2023
 · 
8 min read
Load More